BridgeBio Pharma (BBIO) Business News Oct. 27, 2025, 11:00 UTC BridgeBio Reports Positive Phase 3 Results for Small Molecule BBP-418 in LGMD2I/R9 FORTIFY Study Full text
There are no comments here yet...